310 related articles for article (PubMed ID: 17041886)
61. Antibody microarray for correlating cell phenotype with surface marker.
Ko IK; Kato K; Iwata H
Biomaterials; 2005 Feb; 26(6):687-96. PubMed ID: 15282147
[TBL] [Abstract][Full Text] [Related]
62. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
[TBL] [Abstract][Full Text] [Related]
63. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
Al-Mawali A; Gillis D; Hissaria P; Lewis I
Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
[TBL] [Abstract][Full Text] [Related]
64. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
65. Application of flow cytometry immunophenotyping and multidrug resistance assay in B-cell acute lymphoid leukemia and multiple myeloma.
Jakab K; Gopcsa L; Adam E; Domjan G; Sarkadi B; Paloczi K
Neoplasma; 2005; 52(1):36-42. PubMed ID: 15739024
[TBL] [Abstract][Full Text] [Related]
66. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
67. Role of FAB classification of acute leukemias in era of immunophenotyping.
Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
[TBL] [Abstract][Full Text] [Related]
68. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
69. Impact of immunophenotyping on management of acute leukemias.
Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
[TBL] [Abstract][Full Text] [Related]
70. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
Hanson CA; Ross CW; Schnitzer B
Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
[TBL] [Abstract][Full Text] [Related]
71. [Microarrays and gene expression profiling for the diagnosis in leukemia. From research studies to routine application].
Haferlach T; Bacher U; Kohlmann A; Schnittger S; Kern W; Haferlach C
Med Klin (Munich); 2006 Nov; 101(11):908-14. PubMed ID: 17235479
[TBL] [Abstract][Full Text] [Related]
72. Flow-cytometric quantitation in chronic leukemias.
Lavabre-Bertrand T
Eur J Histochem; 1996; 40 Suppl 1():33-8. PubMed ID: 8839697
[TBL] [Abstract][Full Text] [Related]
73. Detection and monitoring of a concomitant atypical myeloproliferative disorder and chronic lymphocytic leukemia by flow-cytometric immunophenotyping.
McCoy JP; Johnson E; Catalano E; Blumstein L; Overton WR; Gryn J; Donaldson MH
Arch Pathol Lab Med; 1995 Nov; 119(11):1038-43. PubMed ID: 7487404
[TBL] [Abstract][Full Text] [Related]
74. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
75. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
Bacher U; Kohlmann A; Haferlach T
Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
[TBL] [Abstract][Full Text] [Related]
76. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
Hanson CA; Morice WG
Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
[No Abstract] [Full Text] [Related]
77. Childhood acute erythroleukemia diagnosis by flow cytometry.
Sharma A; Buxi G; Walia R; Yadav RB; Sharma S
Indian J Pathol Microbiol; 2011; 54(1):173-5. PubMed ID: 21393910
[TBL] [Abstract][Full Text] [Related]
78. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
79. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
[TBL] [Abstract][Full Text] [Related]
80. Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.
Seegmiller AC; Kroft SH; Karandikar NJ; McKenna RW
Am J Clin Pathol; 2009 Dec; 132(6):940-9. PubMed ID: 19926587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
